Alzheimer disease, attention, and the cholinergic system.
about
The apolipoprotein E gene, attention, and brain functionThe ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.Patients with mild cognitive impairment display reduced auditory event-related delta oscillatory responsesIsoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females.Impaired attention in the 3xTgAD mouse model of Alzheimer's disease: rescue by donepezil (Aricept).Asymmetry in auditory and spatial attention span in normal elderly genetically at risk for Alzheimer's disease.The effects of galantamine treatment on attention and its relationship with cognition and activities of daily living in patients with mild to moderate Alzheimer's disease.Specific patterns of cognitive impairment in patients with idiopathic normal pressure hydrocephalus and Alzheimer's disease: a pilot study.Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease.Concurrent administration of donepezil HCl and sertraline HCl in healthy volunteers: assessment of pharmacokinetic changes and safety following single and multiple oral doses.Smoking, death, and Alzheimer disease: a case of competing risksSustained attention in mild Alzheimer's diseaseCholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health.Corticothalamic network dysfunction and behavioral deficits in a mouse model of Alzheimer's disease.Cholinergic septo-hippocampal innervation is required for trace eyeblink classical conditioning.Longitudinal evaluation of Tau-P301L transgenic mice reveals no cognitive impairments at 17 months of age.Cholinergic Hypofunction in Presbycusis-Related Tinnitus With Cognitive Function Impairment: Emerging Hypotheses.Neuropharmacology of attention
P2860
Q24539024-B6387871-4742-4856-B699-42606C981849Q31145409-56BA2B85-B46D-434C-AE22-C008A99C557AQ33552490-49EF72E9-A858-4B7E-8311-B87186E14DE7Q33563135-4AD59B45-0AAD-4C2D-9245-0FD4092DBAACQ34732823-5AA66F8A-92E2-4A57-8619-C950BA1CB8F4Q34832035-23D782AE-8E25-4E84-B06D-9016F2A60D08Q34996548-5C900CB2-EAB5-4416-B838-CEA59FB19012Q35454667-C8A5A48F-AA97-4315-A289-C30EDD5F9E22Q35486482-33BC8B67-B0CA-4509-957A-F8817CA9F584Q35826258-CC66F933-092A-4F30-AA06-682382941ED6Q35874663-91350D33-4D07-4968-900A-7EBD538DD970Q36656541-99BF2C65-017D-4F28-B37F-EB45D43BECECQ37019704-18EB6279-5B72-4817-9B59-588267CCBDF6Q42423885-F4452F1A-2E0E-4229-B8A9-166E08EB2EC2Q43192344-8402E691-A1ED-4D65-B37A-A9907CCD8384Q52641425-96E4A187-7F07-456D-9F53-9903EE3DA3E6Q55365967-822F6E0F-119E-4D12-87B7-761C5CD5A964Q57156824-A459A3E1-FC73-4279-A57A-9C75180C2474
P2860
Alzheimer disease, attention, and the cholinergic system.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Alzheimer disease, attention, and the cholinergic system.
@en
type
label
Alzheimer disease, attention, and the cholinergic system.
@en
prefLabel
Alzheimer disease, attention, and the cholinergic system.
@en
P1476
Alzheimer disease, attention, and the cholinergic system.
@en
P2093
Lawrence AD
Sahakian BJ
P407
P478
P577
1995-01-01T00:00:00Z